- China Pacific reported a year-to-date life premium income of 217.05 billion yuan.
- This represents a 13% increase compared to the previous year.
- The year-to-date property and casualty insurance premium income is reported at 142.81 billion yuan.
- The growth in property and casualty insurance premiums is a modest 0.4% year-over-year.
- The company is viewed positively by analysts with 18 buy ratings.
- There are 5 hold ratings and no sell ratings for the company.
A look at China Pacific Insurance (Group) Co., Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Pacific Insurance (Group) Company, Ltd. is positioned for a bright future, as indicated by its impressive Smartkarma Smart Scores. With top scores in Value, Dividend, and Growth, the company demonstrates solid fundamentals and potential for long-term success. China Pacific Insurance is an integrated insurance services provider, delivering life and property insurance products through its subsidiaries, highlighting its diversified offerings in a competitive market.
While the company shows strength across various factors, it is worth noting its slightly lower scores in Resilience and Momentum. This suggests that China Pacific Insurance may face some challenges in terms of adapting to market changes quickly. However, with its strong foundation in value, dividends, and growth, coupled with a wide range of insurance products, China Pacific Insurance (Group) Company, Ltd. is well-positioned to sustain its growth and profitability in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
